Testing effectiveness (Phase 2)Study completedNCT03759600
What this trial is testing
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 20